Intrinsic Value of S&P & Nasdaq Contact Us

ETAO International Co., Ltd. ETAOF OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
17/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

ETAO International Co., Ltd. (ETAOF) generated $11.32M in operating cash flow for quarter ending 2022-12-31. After capital expenditures of $0.00, free cash flow was $11.32M.

Free cash flow margin was 19.5% of revenue. Cash conversion ratio was -0.01x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (0/100, Fail) — weak cash flow raises concerns about debt servicing
  • MOAT (36/100, Fail) — limited free cash flow weakens the competitive position
  • INCOME (10/100) — Cash conversion ratio was -0.01x suggests some earnings are non-cash items

Overall SharesGrow Score: 16/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
17/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
36/100
Proven by this page
~
GROWTH
40/100
→ Income
INCOME
10/100
→ Income
ETAO International Co., Ltd. Cash Flow History
Metric TTM Q4 FY2022 Q3 FY2022 Q2 FY2022 Q1 FY2022
Operating Cash Flow $10.88M$11.32M$-38.2K$-179.02K$-223.93K
Capital Expenditure $0.00$0.00$0.00$0.00$0.00
Free Cash Flow $10.88M$11.32M$-38.2K$-179.02K$-223.93K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message